🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Dopamine and Sensorimotor Function in Stuttering

RecruitingPhase 1Ages 18 Years - 65 YearsAllUniversity of California, San Francisco
NCT07215884 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * native speakers of American English * for adults who stutter, presence of stuttering will be confirmed, with onset before age 6 years * Normal hearing * Ages of 18 to 65 years * healthy adults without hearing-language difficulties Exclusion Criteria: * self-reported speech-language-hearing difficulties other than stuttering * self-reported neurological or psychological problems * other medications (drugs that affect dopaminergic system and/or benzodiazepines)
💊

What it tests

  • Aripiprazole 10 MG
  • Placebo
📍

Where

1 site
Biomagentic Imaging Lab
San Francisco, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy